Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial

BACKGROUND: Minimally invasive thrombolytic evacuation of intracerebral hematoma is being investigated in the ongoing phase III clinical trial of Minimally Invasive Surgery plus recombinant Tissue plasminogen activator for Intracerebral hemorrhage Evacuation (MISTIE III). OBJECTIVE: To assess the ac...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurosurgery
Asıl Yazarlar: Fam, Maged D, Hanley, Daniel, Stadnik, Agnieszka, Zeineddine, Hussein A, Girard, Romuald, Jesselson, Michael, Cao, Ying, Money, Lynn, McBee, Nichol, Bistran-Hall, Amanda J, Mould, W Andrew, Lane, Karen, Camarata, Paul J, Zuccarello, Mario, Awad, Issam A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Research—Human—Clinical Studies
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6257031/
https://ncbi.nlm.nih.gov/pubmed/28402516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuros/nyx123
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller